//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
ProfilePosts









Loading...
patients, doctors/health care workers, hospitals, and public health.
Our research is not to inform policymakers, and that will be considered out of scope for NIH funding. This scoping change is already being used during review after the scientific peer review. Notices of “renegotiation” or “rescoping” may be sent to researchers related to this issue
Getting the word out on NIH scoping changes announced yesterday at ASHEcon. As noted on June 8th by the NIH Director, Jay Bhattacharya, grants should not be geared toward policymakers but toward stakeholders who directly benefit from NIH researchers:
In Senate testimony, Brett Matsumoto, Trump's nominee to lead the Bureau of Labor Statistics, promises to maintain the independence of the agency. “It is important for the public to be confident that decisions at the BLS are benign driven by science rather than politics."